Dashboard
Manage Tickers

RIGL RIGEL PHARMACEUTICALS INC

Nasdaq rigel.com


$ 27.74 $ -0.17 (-0.6 %)    

Friday, 17-Oct-2025 16:00:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 27.94
$ 28.02
$ 27.16 x 230
$ 30.00 x 100
$ 27.75 - $ 28.99
$ 13.57 - $ 43.72
383,569
na
501.17M
$ 1.02
$ 5.12
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 03-04-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 03-05-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-01-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 03-07-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-05-2021 03-31-2021 10-Q
19 03-02-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-05-2020 03-31-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
30 05-01-2018 03-31-2018 10-Q
31 03-06-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-01-2017 06-30-2017 10-Q
34 05-02-2017 03-31-2017 10-Q
35 03-07-2017 12-31-2016 10-K
36 11-01-2016 09-30-2016 10-Q
37 08-02-2016 06-30-2016 10-Q
38 05-03-2016 03-31-2016 10-Q
39 03-08-2016 12-31-2015 10-K
40 11-03-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

rigel-pharma-announces-first-patient-enrolled-in-dose-expansion-phase-of-ongoing-phase-1b-study-of-r2891-in-patients-with-rr-lower-risk-mds-earlier-today
Rigel Pharma Announces First Patient Enrol...
10/08/2025 14:29:09

Dose expansion phase will determine the recommended Phase 2 dose of R289 for patients with transfusion dependent R/R lower-risk...

hc-wainwright--co-reiterates-buy-on-rigel-pharmaceuticals-maintains-57-price-target
HC Wainwright & Co. Reiterates Buy on Rige...
10/08/2025 14:19:07

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $57...

freeport-mcmoran-harmony-biosciences-cohu-and-other-big-stocks-moving-lower-on-wednesday
Freeport-McMoRan, Harmony Biosciences, Coh...
09/24/2025 18:18:13

cantor-fitzgerald-maintains-neutral-on-rigel-pharmaceuticals-raises-price-target-to-32
Cantor Fitzgerald Maintains Neutral on Rig...
08/06/2025 14:12:29

Cantor Fitzgerald analyst Kristen Kluska maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and raises the price t...

rigel-pharmaceuticals-q2-eps-328-beats-019-estimate-sales-101685m-beat-48142m-estimate
Rigel Pharmaceuticals Q2 EPS $3.28 Beats $...
08/05/2025 20:11:24

Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly earnings of $3.28 per share which beat the analyst consensus estimate of...

rigel-pharmaceuticals-raises-fy2025-sales-guidance-from-200000m-210000m-to-210000m-220000m-vs-201095m-est
Rigel Pharmaceuticals Raises FY2025 Sales ...
08/05/2025 20:05:44

Rigel Pharmaceuticals (NASDAQ:RIGL) raises FY2025 sales outlook from $200.000 million-$210.000 million to $210.000 million-$220...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

what-to-expect-from-rigel-pharmaceuticalss-earnings
What to Expect from Rigel Pharmaceuticals'...
08/04/2025 20:06:18

rigel-pharmaceuticals-to-present-final-gavreto-phase-12-arrow-study-data-in-ret-fusion-positive-nsclc-and-solid-tumors-along-with-supportive-rezlidhia-data-for-midh1-rr-aml-at-asco-and-eha-2025-conferences
Rigel Pharmaceuticals To Present Final GAV...
05/22/2025 21:36:10

Final data from the GAVRETO® (pralsetinib) Phase 1/2 ARROW study in RET fusion-positive NSCLC and other solid tumors  Supportiv...

rockwell-automation-posts-better-than-expected-earnings-joins-oscar-health-charles-river-laboratories-walt-disney-voya-financial-and-other-big-stocks-moving-higher-on-wednesday
Rockwell Automation Posts Better-Than-Expe...
05/07/2025 14:10:28

cantor-fitzgerald-maintains-neutral-on-rigel-pharmaceuticals-raises-price-target-to-23
Cantor Fitzgerald Maintains Neutral on Rig...
05/07/2025 14:01:00

Cantor Fitzgerald analyst Kristen Kluska maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and raises the price t...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
05/07/2025 12:09:25

rigel-pharmaceuticals-affirms-fy2025-sales-guidance-of-20000m-21000m-vs-22879m-est
Rigel Pharmaceuticals Affirms FY2025 Sales...
05/06/2025 21:44:07

Rigel Pharmaceuticals (NASDAQ:RIGL) affirms FY2025 sales outlook from $200.00 million-$210.00 million to $200.00 million-$210.0...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/06/2025 21:06:18

rigel-pharmaceuticals-q1-eps-063-beats-009-estimate-sales-5330m-beat-4387m-estimate
Rigel Pharmaceuticals Q1 EPS $0.63 Beats $...
05/06/2025 20:31:16

Rigel Pharmaceuticals (NASDAQ:RIGL) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of...

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

a-preview-of-rigel-pharmaceuticalss-earnings
A Preview Of Rigel Pharmaceuticals's Earnings
05/05/2025 20:02:59

rigel-announces-settlement-agreement-with-annora-resolving-tavalisse-patent-litigation
Rigel Announces Settlement Agreement With ...
03/27/2025 12:08:36

citigroup-maintains-buy-on-rigel-pharmaceuticals-raises-price-target-to-55
Citigroup Maintains Buy on Rigel Pharmaceu...
03/06/2025 15:15:35

Citigroup analyst Yigal Nochomovitz maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and raises the price target fro...

b-riley-securities-maintains-neutral-on-rigel-pharmaceuticals-raises-price-target-to-24
B. Riley Securities Maintains Neutral on R...
03/05/2025 17:28:57

B. Riley Securities analyst Kalpit Patel maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and raises the price t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION